Back to Market返回行情
AP
APUS Apimeds Pharmaceuticals US, Inc
AMEXHealthcare$5.02-21.44%ClosedMarket Cap: $7.6M
As of 2026-09-29 16:00
Why APUS matters now
Apimeds Pharmaceuticals US, Inc (APUS) is a US stock in Healthcare. The latest InvestLog snapshot shows $5.02 with -21.44% on the session and $7.6M in market capitalization.
The latest indexable market news headline is "MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media" from GlobeNewsWire.
Latest News
MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & MediaGlobeNewsWire · 2026-09-29
Apimeds Pharmaceuticals Stock Skyrockets Thursday: What's Happening?Benzinga · 2026-09-24
MindWave Innovations Signs Agreement to Build and Operate AQUAEChain, a Platform for Insured ALCI CreditsGlobeNewsWire · 2026-09-24
IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc.GlobeNewsWire · 2026-09-18
NILA Token Now Available to Eligible U.S. Users on Webot, a Licensed U.S. Cryptocurrency ExchangeGlobeNewsWire · 2026-08-03
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
AMEX
Beta
0.15
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.